Skip to Content

Praxsyn Corp PXYN

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PXYN is trading at a 34% discount.
Price
$0.00
Fair Value
$9.69
Uncertainty
Extreme
1-Star Price
$8.15
5-Star Price
$9.88
Economic Moat
Cstpvft
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PXYN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$634.67
Volume/Avg
653,390 / 914,280

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
75

Valuation

Metric
PXYN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
PXYN

Financial Strength

Metric
PXYN
Quick Ratio
0.41
Current Ratio
0.43
Interest Coverage
2.27
Quick Ratio
PXYN

Profitability

Metric
PXYN
Return on Assets (Normalized)
−2.87%
Return on Equity (Normalized)
−18.20%
Return on Invested Capital (Normalized)
69.14%
Return on Assets
PXYN
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRBbjzxbdxcqSbrljr$70.5 Bil
ZTS
Zoetis Inc Class AGvctjjyjfQyc$69.4 Bil
HLN
Haleon PLC ADRPrgwxfzcDrl$36.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRTsdcpgkThy$14.9 Bil
VTRS
Viatris IncZbsskxyfSyjh$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRLjhjvqyfMpc$12.0 Bil
CTLT
Catalent IncVylzwvfXkfvk$10.1 Bil
PRGO
Perrigo Co PLCJpmstxyQpsq$4.1 Bil
CURLF
Curaleaf Holdings IncCxrptbqnCjwc$3.7 Bil
PBH
Prestige Consumer Healthcare IncVwzdvlgnSlffkxr$3.4 Bil

Sponsor Center